谷歌浏览器插件
订阅小程序
在清言上使用

A Randomised Phase II Clinical Trial of Low-Dose Cyclophosphamide and Transarterial Chemoembolization (TACE) with or Without Vaccination with Dendritic Cells (DC) Pulsed with HepG2 Lysate Ex Vivo in Patients with Hepatocellular Carcinoma (HCC): the ImmunoTACE Trial.

JOURNAL OF CLINICAL ONCOLOGY(2022)

引用 1|浏览47
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要